The partnership will combine Tecan’s liquid handling and automation expertise with UgenTec’s FastFinder software to provide high-throughput solutions for molecular testing.
Read More
Researchers have developed a blood test that uses cell-free DNA to gauge the damage that covid-19 inflicts on cells, tissues, and organs, and could help aid in the development of new therapies.
Read More
This winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last, according to a report in The Atlantic.
Read More
T2 Biosystems’ panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the United States.
Read More
With BARDA funding, Visby will advance a next-generation device to detect flu and/or covid-19 in one hand-held rapid PCR test for use at the point-of-need and eventually in consumers’ homes as an over-the-counter test.
Read More